Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
<p>Abstract</p> <p>Recently, the Food and Drug Administration placed a "black box" label on etanercept, and other tumor necrosis factor inhibitors used to treat childhood arthritis, warning of the risk of malignancies. The Food and Drug Administration made their decision...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
BMC,
2010-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |